Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
The Neurobiology of Suicide
NCT02543983Phase 2Recruiting
- Sponsor
- National Institute of Mental Health
- Start
- Dec 2015
- Primary completion
- Jul 2030
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of ketamine in suicidal ideation, sponsored by National Institute of Mental Health. Started Dec 2015; status: recruiting.
02
Drugs
ketamine
03
Conditions
suicidal ideation
Beyond the preview
Go deeper on NCT02543983.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02543983.